Device type · DCF
Albumin, Antigen, Antiserum, Control
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DCF
Immunology
Device class
Class II
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
24
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Albumin, Antigen, Antiserum, Control
- Product code
- DCF
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5040
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DCF
Latest FDA decisions
K153560 · Decided Aug 25, 2016 · 255 days after receipt
Device type: Albumin, Antigen, Antiserum, Control (DCF) · Laboratory Medicine & Pathology
K143118 · Decided May 26, 2015 · 208 days after receipt
Device type: Albumin, Antigen, Antiserum, Control (DCF) · Laboratory Medicine & Pathology
Reports received
24
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
24
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 2 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 2 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 1 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 2 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 13 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 3 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Low Test Results13
- High Test Results8
- Non Reproducible Results4
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions24
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Ortho Clinical Diagnostics Inc
Z-0739-2020 · Started Oct 14, 2019
Reason given: Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days
Cause as FDA categorized it: Device Design
Z-2124-2017 · Started Apr 24, 2017
Reason given: Beckman Coulter has confirmed that MA Reagent Lot M609458 may recover outside the lower limit of the published insert range for Beckman Coulter Urine Protein Control Level 1.
Cause as FDA categorized it: Under Investigation by firm
Z-1831-2013 · Started Apr 30, 2013 · Posted by FDA Jul 30, 2013
Reason given: Product fails to meet the accuracy at the low end of the measuring range.
Cause as FDA categorized it: Material/Component Contamination
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.